184 related articles for article (PubMed ID: 23088167)
1. Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection.
Özkaya Şahin G; Månsson F; Palm AA; Vincic E; da Silva Z; Medstrand P; Norrgren H; Fenyö EM; Jansson M
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):470-8. PubMed ID: 23088167
[TBL] [Abstract][Full Text] [Related]
2. Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1.
Ozkaya Sahin G; Holmgren B; da Silva Z; Nielsen J; Nowroozalizadeh S; Esbjörnsson J; Månsson F; Andersson S; Norrgren H; Aaby P; Jansson M; Fenyö EM
J Virol; 2012 Jan; 86(2):961-71. PubMed ID: 22072782
[TBL] [Abstract][Full Text] [Related]
3. Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.
Özkaya Şahin G; Holmgren B; Sheik-Khalil E; da Silva Z; Nielsen J; Nowroozalizadeh S; Månsson F; Norrgren H; Aaby P; Fenyö EM; Jansson M
J Virol; 2013 Jan; 87(1):273-81. PubMed ID: 23077299
[TBL] [Abstract][Full Text] [Related]
4. Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1.
Tay MZ; Kunz EL; Deal A; Zhang L; Seaton KE; Rountree W; Eudailey JA; Heptinstall J; McRaven MD; Matias E; McGuire E; Yates NL; Perez LG; Montefiori DC; Overman RG; Hope TJ; Shen X; Kalilani L; Fouda GG; Tomaras GD; Permar SR
J Virol; 2019 Apr; 93(7):. PubMed ID: 30700599
[TBL] [Abstract][Full Text] [Related]
5. Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections.
Rodriguez SK; Sarr AD; MacNeil A; Thakore-Meloni S; Gueye-Ndiaye A; Traoré I; Dia MC; Mboup S; Kanki PJ
J Virol; 2007 May; 81(10):5331-8. PubMed ID: 17301136
[TBL] [Abstract][Full Text] [Related]
6. Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection.
Kong R; Li H; Bibollet-Ruche F; Decker JM; Zheng NN; Gottlieb GS; Kiviat NB; Sow PS; Georgiev I; Hahn BH; Kwong PD; Robinson JE; Shaw GM
J Virol; 2012 Jan; 86(2):947-60. PubMed ID: 22031948
[TBL] [Abstract][Full Text] [Related]
7. HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies.
Fouda GG; Yates NL; Pollara J; Shen X; Overman GR; Mahlokozera T; Wilks AB; Kang HH; Salazar-Gonzalez JF; Salazar MG; Kalilani L; Meshnick SR; Hahn BH; Shaw GM; Lovingood RV; Denny TN; Haynes B; Letvin NL; Ferrari G; Montefiori DC; Tomaras GD; Permar SR;
J Virol; 2011 Sep; 85(18):9555-67. PubMed ID: 21734046
[TBL] [Abstract][Full Text] [Related]
8. Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals.
Lizeng Q; Nilsson C; Sourial S; Andersson S; Larsen O; Aaby P; Ehnlund M; Björling E
J Virol; 2004 Jul; 78(13):7016-22. PubMed ID: 15194778
[TBL] [Abstract][Full Text] [Related]
9. Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism.
Marcelino JM; Borrego P; Nilsson C; Família C; Barroso H; Maltez F; Doroana M; Antunes F; Quintas A; Taveira N
AIDS; 2012 Nov; 26(18):2275-84. PubMed ID: 23151495
[TBL] [Abstract][Full Text] [Related]
10. Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth.
Chukwuma VU; Kose N; Sather DN; Sapparapu G; Falk R; King H; Singh V; Lampley R; Malherbe DC; Ditto NT; Sullivan JT; Barnes T; Doranz BJ; Labranche CC; Montefiori DC; Kalams SA; Haigwood NL; Crowe JE
PLoS One; 2018; 13(12):e0209437. PubMed ID: 30566528
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients.
Burrer R; Salmon-Ceron D; Richert S; Pancino G; Spiridon G; Haessig S; Roques V; Barre-Sinoussi F; Aubertin AM; Moog C
J Virol; 2001 Jun; 75(11):5421-4. PubMed ID: 11333928
[TBL] [Abstract][Full Text] [Related]
12. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
Li H; Zony C; Chen P; Chen BK
J Virol; 2017 May; 91(9):. PubMed ID: 28148796
[TBL] [Abstract][Full Text] [Related]
13. Efficient neutralization of primary isolates by the plasma from HIV-1 infected Indian children.
Prakash SS; Chaudhary AK; Lodha R; Kabra SK; Vajpayee M; Hazarika A; Bagga B; Luthra K
Viral Immunol; 2011 Oct; 24(5):409-13. PubMed ID: 22004138
[TBL] [Abstract][Full Text] [Related]
14. Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy.
Hu X; Hong K; Zhao C; Zheng Y; Ma L; Ruan Y; Gao H; Greene K; Sarzotti-Kelsoe M; Montefiori DC; Shao Y
J Gen Virol; 2012 Oct; 93(Pt 10):2267-2278. PubMed ID: 22791603
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes.
Ruppach H; Nara P; Raudonat I; Elanjikal Z; Rübsamen-Waigmann H; Dietrich U
J Virol; 2000 Jun; 74(12):5403-11. PubMed ID: 10823844
[TBL] [Abstract][Full Text] [Related]
16. Humoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women.
Mestecky J; Wei Q; Alexander R; Raska M; Novak J; Moldoveanu Z
Am J Reprod Immunol; 2014 Jun; 71(6):600-7. PubMed ID: 24494997
[TBL] [Abstract][Full Text] [Related]
17. Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women.
Mkhize NN; Durgiah R; Ashley V; Archary D; Garrett NJ; Karim QA; Karim SS; Moore PL; Yates N; Passmore JA; Tomaras GD; Morris L
AIDS; 2016 Apr; 30(7):1005-14. PubMed ID: 26836790
[TBL] [Abstract][Full Text] [Related]
18. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M
Front Immunol; 2018; 9():244. PubMed ID: 29651286
[TBL] [Abstract][Full Text] [Related]
19. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.
Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C
Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476
[TBL] [Abstract][Full Text] [Related]
20. Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma.
Yuste E; Sanford HB; Carmody J; Bixby J; Little S; Zwick MB; Greenough T; Burton DR; Richman DD; Desrosiers RC; Johnson WE
J Virol; 2006 Mar; 80(6):3030-41. PubMed ID: 16501112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
